Decision support for drug development

PhinC Development is the expert partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research.

Thanks to a multidisciplinary team with thorough field experience, PhinC Development helps to take the best decisions concerning drug development using all existing pharmacology and pharmacometrics modeling & simulation (M&S) tools.

PhinC Development offers more rapid and efficient solutions than one-time consulting or CROs.

PhinC Development designs and guides all clinical operations (files, protocols, global development strategy) and coordinates all clinical research actors to optimize your drug development from the drug candidate selection to phase IIb (or later). The application of the MIDD concept "Model Informed Drug Development" will significantly optimize the development of your drug candidate at different levels by:

  • Providing essential data on the product under study from the earliest stages of development
  • Strengthening scientific justifications during regulatory submissions
  • Optimizing time and means to implement

PhinC Development brings you the best MIDD tool at each step to go on to the next step efficiently.

  • PBPK Physiological Based Pharmacokinetic
  • PopPK Population pharmacokinetic
  • PKPD Pharmacokinetic/ Pharmacodynamic
  • Simulation

Our experts in clinical development

PhinC Development has highly qualified experts in clinical pharmacology, pharmacokinetics, and biostatistics in a wide range of therapeutic areas. All members of the team have a deep knowledge in drug development and bring their expertise to develop useful and creative PopPK, PBPK and PK/PD models.

They also master the internationally recognized software packages as NONMEM®, SAS®, WinnonLin®, Monolix® and GastroPlus®.

Since the creation of PhinC, the founders have wanted to develop scientific operations around an agile and expert team, but at the same time, meeting the best standards of the pharmaceutical industry, relying in particular on highly qualified resources in the fields of quality assurance, legal, financial, HSE, marketing and communication.

PhinC currently has 16 employees, including 12 operational staff. Our pharmacometricians all have a postgraduate degree in pharmacology, pharmacokinetics, biostatistics and are pharmacists, doctors or research engineers.




Proven expertise backed by a solid IT infrastructure and a robust Quality System.
Read more


PhinC vision is directly inspired by the principles and professional ethics that have bound the 4 co-founders.
Read more
Club Phase 1
GMP - Groupe de Métabolisme et Pharmacocinétique
Oncodesign services
Paris Saclay
France Biotech
Paris Region Business Club
French Tech Paris-Saclay